The protocol for this two-group blinded controlled randomized clinical trial study was confirmed with the clinical trial code
IRCT20170703034873N3 and the code of ethics
IR.ZAUMS.REC.1401.176 by the Vice-Chancellor for Research and Technology of Zahedan University of Medical Sciences. The participants were selected from all pregnant women candidates for non-emergency cesarean section who underwent cesarean surgery in the operating room of Ali Ibne Abitalib Hospital affiliated with Zahedan University of Medical Sciences. The inclusion criteria were non-emergency cesarean section candidates with obstetric and non-obstetric indications, at least 18 years of age, singleton pregnancy, gestational age greater than or equal to 37 weeks, absence of underlying diseases such as liver/severe kidney disorders/diabetes, and severe anemia (Hct < 33% or Hb < 11g/dL), not receiving blood products within 10 days before surgery, not using immunosuppressive drugs (cortones), no history of infectious diseases and severe malnutrition in the last 6 months, BMI less than 35, and not detecting placenta accreta or placenta previa in ultrasound before cesarean section. The exclusion criteria were not being discharged in the first 24 hours after surgery due to any birth complications and hospitalization for more than 1 week after cesarean section, fever above 38 degrees from the time of admission to 48 hours after cesarean section, and the patient’s non-referral in the one-month follow-up.
Taking into account the severity of surgical wound infection in a similar study (Alizadeh et al.), (
31), the sample size was estimated with a 95% confidence interval and 95% test power as 19 persons per group using the following formula. To ensure sample adequacy for data analysis and considering any possible dropout, the sample size was considered to be 30 patients in each group (60 patients in total).
Z1-α/2 = 1.96; P1 = 1.8; P2 = 3.6; Z1-β = 1.64
The participants were selected from among pregnant women candidates for non-emergency cesarean section who visited the Obstetrics and Gynecology Department of Ali Ibne Abitalib Hospital using convenience sampling in autumn 2022. The selected women received some instructions about the objectives of the study and the research protocol and signed an informed consent form. The patients were assigned to the intervention and control groups using random permuted blocks. The data were collected using a checklist for gathering the patients’ demographic, pregnancy, and surgical data and the REEDA Scale.
The REEDA Scale was developed by Davidson (1974) to evaluate the perineal conditions. This scale measures five symptoms, such as Redness (Hyperaemia), oedema, ecchymosis, discharge, and approximation of the wound edges (Coaptation). Each symptom is scored 0 to 3, with 0 indicating “absence of the symptom” and 3 indicating “the existence of severe symptom.” The total score is interpreted as follows: 0 means “recovery,” a score of 1 - 5 indicates “moderate recovery,” a score of 6 - 10 indicates “weak recovery,” and a score of 11 - 15 indicates “no recovery” (
32). In the present study, a score greater than 6 was considered to mean the occurrence of surgical wound infection.
The content validity of the REEDA Scale was confirmed by Pore by administering it to 40 doctors and nurses, and its reliability was confirmed with Cronbach's alpha of 0.9 (
33). Moreover, Amani et al. assessed the reliability of the REEDA Scale through inter-rater agreement. To this end, the scale was simultaneously administered by the researcher and a subject-matter expert for 10 women on the fifth day after delivery, and Spearman's test was used to measure the inter-rater correlation. The resulting value was 0.85, confirming the reliability of the instrument (
34).
The participants’ demographic, pregnancy, and surgical data were collected through interviews with the patients and by reviewing their medical files. The patients in the intervention group were treated using the care bundle for the prevention of surgical site infection. To do so, pre-surgery care was performed for the patients first. After the patient was called to the operating room, intraoperative care was provided followed by postoperative care in the recovery room and the surgical department. The SSI prevention care bundle focused on preoperative, intraoperative, and postoperative nursing interventions.
Preoperative nursing interventions involved taking a shower the day before surgery preferably with an antibacterial detergent, trimming excess hair at the surgical site with an electric clipper preferably one hour before sending the patient to the operating room, washing the surgical site with a 2% chlorhexidine disinfectant solution, dressing the surgical site with sterile gauze and prophylaxis antibiotic injection one hour before sending the patient to the operating room. These procedures were performed in the Gynecological Surgery Department. Intraoperative nursing interventions involve preparing the surgical site with a 7.5% brown povidone-iodine disinfectant solution, dyeing the surgical site with a 10% green povidone-iodine disinfectant solution, accurately controlling arterial blood oxygen saturation (SpO2) above 95% and oxygen therapy (if needed), strict control of glucose (less than 200mg/dL), and maintaining the patient's normothermia (above 36°C) during surgery and in the recovery room by using hot water bags and blankets.
Postoperative nursing interventions involve maintaining the surgical site dressing for at least 24 hours after surgery, washing and dressing the wound with sterile waterproof dressing prepared by the researcher on the second day after surgery, teaching the patient how to take care of the wound at home (daily shower, washing the wound with baby shampoo and drying it with a hair dryer or warm towel from 48 hours after the operation), full use of the prescribed oral antibiotic, proper nutrition containing protein, taking iron and vitamin A and C, using an abdominal brace (preventing the abdomen from falling on the surgical incision), teaching the symptoms of surgical wound infection, and the completion of the wound care checklist by the patient.
The patients in the control group received only the routine care of the surgical department and operating room. The surgical incision was examined through direct observation and using the REEDA Scale by the researcher 24 hours after surgery at the time of changing the dressing, each time of washing the wound, on the tenth day at the time of suture removal, and on the thirtieth day.
The patients in both groups were followed up for one month after surgery. An educational pamphlet about wound infection symptoms was given to the patients at the time of education during the discharge so that they could refer if any of the symptoms of infection occurred. From the time of discharge until 30 days after surgery, the researcher contacted the patients once a week and reminded them about how to take care of the wound and complete the checklist. The collected data were analyzed with SPSS-21 software at a significance level of less than 0.05 (P < 0.05). The data were summarized using descriptive statistics (frequency, mean, and standard deviation). First, the normality of the data was checked using the Shapiro-Wilk test, and since the data followed a normal distribution pattern, parametric tests were used for data analysis. Independent samples t-test was used to compare the quantitative variables between the two groups, and the chi-square test was used to check the independence or dependence of qualitative variables with each other. The chi-square test was also used to check the incidence of infection in the two groups.